Back to MW MARSHALL WACE, LLP

CNTBCNTB
4 quarters

Position history for MWMARSHALL WACE, LLP's holdings in CONNECT BIOPHARMA HLDGS LTD

MARSHALL WACE, LLP holds 335,642 shares of CNTB (CONNECT BIOPHARMA HLDGS LTD), worth $798,830 as of 2026-Q2. The position was increased (+408.4% shares). CNTB represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$798,830

Current Shares

335,642

Total Value Change

+$712,944

Total Shares Change

+277,611

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
335,642
+408.4%
$798,8300.0%$2.38
40
2026-Q1
Decreased
66,013
-48.6%
$172,9540.0%$2.48
0
2025-Q4
Increased
128,368
+121.2%
$361,9980.0%$2.70
38
2025-Q3
New
58,031
-
$85,8860.0%$1.32
30

Other major holders of CNTB: BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used